UroGen Pharma's Series A Round

UroGen Pharma raised a round of funding on May 22, 2013.

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with…

Articles about UroGen Pharma's Series A Round: